So many women with endometriosis hold on to the hope that menopause will finally be their finish line. Finding out that perimenopause can actually turn the volume up — not down — on pelvic pain feels like a cruel twist. This page exists because that experience deserves a real explanation, not a dismissal.
Learn more about Rose →In perimenopause, estrogen doesn't decline in a straight line — it surges unpredictably before eventually dropping, and those surges are often higher than anything experienced in regular reproductive years. Endometriosis lesions are estrogen-dependent tissue, meaning they can be stimulated to grow or become more active during these peaks. This is the core reason why 'waiting for menopause' isn't always the relief strategy it sounds like.
Progesterone has long been understood to counterbalance estrogen's proliferative effects on endometrial-like tissue, and perimenopause is characterised by progesterone falling away first — often well before estrogen does. This means the natural hormonal check on lesion activity is weakened at the same time estrogen is spiking erratically. The result is an imbalance that can tip conditions in favour of increased inflammation and pain.
Years of chronic pelvic pain from endometriosis can rewire the central nervous system in a process called central sensitisation, where pain signals are amplified even when the underlying stimulus hasn't changed. Perimenopause independently lowers pain thresholds through its effects on serotonin and opioid receptor sensitivity, potentially compounding this effect. Women may find that pain that was previously manageable suddenly feels overwhelming, without any new lesion growth to explain it.
Retrograde menstruation — where menstrual blood flows backward through the fallopian tubes — is one of the leading theories behind endometriosis maintenance and spread. Perimenopausal cycles are notoriously irregular, with some being heavier than normal and others skipped entirely, making the volume and timing of retrograde flow harder to predict or manage. Heavier breakthrough bleeds in particular may expose the pelvic cavity to larger volumes of endometrial material.
The pelvic floor muscles depend partly on estrogen to maintain tone and flexibility, and as estrogen becomes less consistent in perimenopause, pelvic floor dysfunction becomes more common. For women with deep infiltrating endometriosis — where lesions penetrate the bowel, bladder, or uterosacral ligaments — pelvic floor changes can worsen the pulling, pressure, and referred pain these lesions already cause. Distinguishing endometriosis pain from pelvic floor pain in this context is genuinely difficult and often requires specialist input.
Night sweats, insomnia, and disrupted sleep architecture are hallmark symptoms of perimenopause, and sleep deprivation is one of the most well-documented ways to lower the body's tolerance for pain. For someone already managing chronic pelvic pain, the sleep disruption of perimenopause creates a feedback loop: pain disrupts sleep, and poor sleep makes the pain feel worse the next day. This cycle can escalate quickly and is often missed as a driver of worsening endometriosis symptoms.
Ovarian endometriomas — the cysts formed when endometriosis involves the ovary — are particularly resistant to regression and have been shown in studies to persist well into the menopause transition. Because the ovaries themselves continue producing some estrogen in perimenopause, endometriomas have a local hormone environment that may sustain them even as systemic estrogen eventually falls. Surgery to remove these cysts earlier in life can affect ovarian reserve and complicate the hormonal picture further.
Menopausal hormone therapy (MHT) is often recommended for managing perimenopause symptoms, but for women with endometriosis, the type, route, and balance of hormones used requires careful thought. Estrogen-only MHT carries a theoretical risk of stimulating residual lesions, and combined preparations need to be matched to the individual's lesion history and surgical status. This doesn't mean MHT is off the table — it means the conversation with a specialist needs to be more specific than it would be for someone without endometriosis.
Many perimenopause symptoms — bloating, fatigue, pelvic pressure, mood changes, and altered bowel habits — overlap almost exactly with endometriosis symptoms, making it genuinely difficult to know which condition is driving what on any given day. This overlap can lead clinicians to attribute everything to 'the menopause' and miss active endometriosis, or conversely to focus entirely on the endometriosis and undertreat the perimenopause. Women in this situation often benefit most from a gynaecologist who is experienced in both conditions simultaneously, rather than bouncing between separate specialists.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.